Wall Street Unplugged
Episode: 541August 10, 2017

Chris MacIntosh: World Out of Whack

“Investing is a matter of probabilities… Not how things should be”

Welcome back to another episode of Wall Street Unplugged.

Today I’m joined by the one-of-a-kind, Chris MacIntosh – Co-Manager of the Asymmetric Opportunities Fund and founder & owner of the popular financial publication, Capitalist Exploits.

Chris has a track-record unlike anyone I’ve met.

Whether it’s speculating on events like Brexit and Trump’s victory, to predicting Bitcoin’s uprising or the collapse of the South African Rand – Chris has never been afraid to ask the questions people don’t want to.

He focuses on macroeconomic trends that contribute to massive market disconnects.

He calls it: Exploiting asymmetry in the markets…

Tune in as Chris unfolds his theses on the topics of bitcoin, blockchain, private-equity, European bond markets, and one hated energy sector that will be the darling of the next decade.

In a world riddled with dangerous thoughts and unsound monetary shenanigans, you’ve come to the right place.

Good Investing,

Frank Curzio

What’s really moving these markets?
Get free daily updates
More Wall Street Unplugged
Donald Trump

Trump’s win will benefit these sectors

These sectors will surge under Trump… Time to sell solar stocks? … Financial stocks to buy and sell… Buy this crypto stock… Why Europe, China, and gold are selling off… Will oil stocks plummet? … And more interest rate cuts?

Starbucks Coffee

Is Starbucks uninvestable?

Election predictions: The betting markets vs. the media… Why is this billionaire avoiding fixed income? … Gold, Bitcoin, and bonds are all saying the same thing about inflation… Is Starbucks (SBUX) uninvestable? … And GM (GM) is poised to soar.

Healthcare

Buy this healthcare stock before December 4

The best election outcome for stocks… How Polymarket is different from other polls… Big tech's transition to nuclear power… What earnings are saying about a banking crisis… What ASML's (ASML) plunge means for semiconductors… And a screaming buy in healthcare.